Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study). (Q33452218)

26 July 2017

Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study). (English)

1 reference

26 July 2017

1 reference

1 reference

Pinkerton CR

1

1 reference

26 July 2017

Bowman A

series ordinal

2

1 reference

26 July 2017

Holtzel H

series ordinal

3

1 reference

26 July 2017

Chessells JM

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

Archives of Disease in Childhood

26 July 2017

1 reference

26 July 2017

62

1 reference

26 July 2017

12-18

1 reference

26 July 2017

1

1 reference

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Infection during remission induction in childhood leukaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Acute lymphoblastic leukemia: current status of therapy in children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Childhood acute lymphoblastic leukaemia: the late effects of treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Risks and benefits of intensive treatment of acute leukaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Cytosine-arabinoside-induced colitis and peritonitis: nonoperative management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1778158

31 October 2018

Antifungal chemotherapy

1 reference

12 December 2020

Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group

1 reference

12 December 2020

The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy

1 reference

12 December 2020

The acute abdomen in the immunologically compromised child

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.62.1.12

1 reference

26 July 2017

1 reference

26 July 2017

1 reference